Matinas biopharma to webcast conference call discussing first quarter 2022 financial and operational results on may 12, 2022

Bedminster, n.j., may 05, 2022 (globe newswire) -- matinas biopharma holdings, inc. (nyse amer: mtnb), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (lnc) platform technology, today announced the company will host a conference call and live audio webcast on thursday, may 12, 2022 at 8:30 a.m. et to discuss operational and financial results for the first quarter ended march 31, 2022.
MTNB Ratings Summary
MTNB Quant Ranking